cyclovalone

This page covers all cyclovalone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Transcription factor AP-1, Nuclear factor NF-kappa-B p105 subunit, Integrase.

Targets

Transcription factor AP-1, Nuclear factor NF-kappa-B p105 subunit, Integrase

Phase 2 pipeline (1)

• Cycvalon · Immunology
  Cycvalon works by blocking the NF-kappa-B pathway, which helps regulate inflammation and immune responses.

Patent intelligence

• cyclovalone patent landscape — aggregated cliff calendar, attackable patents, originator estates